Insulet Corp: Form 10-Q for the period ended Jun 30, 2013
Filed with the SEC on Aug 8, 2013 and accepted by EDGAR at Aug 7, 2013, 21:41 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-04-01 to 2013-06-30 | $60.1m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2013-01-01 to 2013-06-30 | $117.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2013-04-01 to 2013-06-30 | $33.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2013-01-01 to 2013-06-30 | $65.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2013-04-01 to 2013-06-30 | $26.8m | us-gaap:GrossProfit |
| Gross profit | 6 months2013-01-01 to 2013-06-30 | $52.0m | us-gaap:GrossProfit |
| Research and development | 3 months2013-04-01 to 2013-06-30 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2013-01-01 to 2013-06-30 | $9.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2013-04-01 to 2013-06-30 | −$5.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-01-01 to 2013-06-30 | −$12.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-04-01 to 2013-06-30 | $0 | us-gaap:InterestExpense |
| Interest expense | 6 months2013-01-01 to 2013-06-30 | $0 | us-gaap:InterestExpense |
| Income tax | 3 months2013-04-01 to 2013-06-30 | $118.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2013-01-01 to 2013-06-30 | $249.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-04-01 to 2013-06-30 | −$10.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2013-01-01 to 2013-06-30 | −$21.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-04-01 to 2013-06-30 | −$0.20 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2013-01-01 to 2013-06-30 | −$0.40 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2013-01-01 to 2013-06-30 | $3.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2013-01-01 to 2013-06-30 | $2.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-06-30 | $150.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-06-30 | $197.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-06-30 | $286.2m | us-gaap:Assets |
| Current liabilities | At period end2013-06-30 | $33.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-06-30 | $147.8m | us-gaap:Liabilities |
| Long-term debt | At period end2013-06-30 | $108.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-06-30 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2013-06-30 | $138.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-13-000025. Last ingested by Listed: Nov 14, 2026, 12:01 ET. Listed shows no prices and gives no investment advice.